| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.6M | -8.8% |
| Cost of Revenue | $826K | +30.1% |
| Gross Profit | $798K | -30.4% |
| R&D Expense | $26K | -86.2% |
| SG&A Expense | $7.4M | -21.3% |
| Operating Income | -$10.9M | +22.3% |
| Income Tax | $0 | — |
| Net Income | -$12.7M | +9.4% |
| EPS (Basic) | -$2.32 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $735K | -91.6% |
| Accounts Receivable | $746K | +123.4% |
| Inventory | $386K | -22.0% |
| Current Assets | $2.2M | -77.9% |
| Total Assets | $5.0M | -65.5% |
| Current Liabilities | $3.6M | -9.1% |
| Total Liabilities | $5.2M | -15.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $10K | -96.6% |
| +33.3% |
| Stockholders' Equity |
| -$203K |
| -102.4% |